サマリー

ホルモン補充療法の世界市場 2024-2028
ホルモン補充療法市場は、2023-2028年に84億4000万米ドルの成長が予測され、予測期間中のCAGRは6.67%で加速すると予測されています。当レポートでは、ホルモン補充療法市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、革新的なホルモン補充療法製品の開発、ホルモン障害の有病率の増加、世界的な医療支出の増加が牽引しています。
Technavio社のホルモン補充療法市場は以下のように分類されます：
流通チャネル別
- 病院薬局
- 小売薬局
- オンライン薬局
タイプ別
- エストロゲン・プロゲステロン補充療法
- 甲状腺ホルモン補充療法
- HGH補充療法
- その他
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、今後数年間のホルモン補充療法市場の成長を促進する主な理由の一つとして、ホルモン補充療法の用途拡大を挙げている。また、更年期障害に対する考え方の文化的転換や予防医療への注目の高まりは、市場の大きな需要につながるでしょう。
本レポートでは、ホルモン補充療法市場について以下の領域をカバーしています：
- ホルモン補充療法市場のサイジング
- ホルモン補充療法市場予測
- ホルモン補充療法市場の産業分析
本レポートでは、ホルモン補充療法市場の主要ベンダーであるAbbott Laboratories社、AbbVie Inc.社、Amgen Inc、Bayer AG、Besins Healthcare Monaco、Eli Lilly and Co.、Endo International Plc、F. Hoffmann La Roche Ltd.、久光製薬株式会社、Lupin Ltd.、Merck KGaA、Mithra Pharmaceuticals SA、Novartis AG、Novo Nordisk AS、Pfizer Inc.、Teva Pharmaceutical Industries Ltd.、Viatris Inc.などです。また、ホルモン補充療法市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/hormone-replacement-therapy-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global hormone replacement therapy market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global hormone replacement therapy market 2018 - 2022 ($ billion)
o 4.2 Distribution Channel Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
o 4.3 Type Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Hospital pharmacies - Market size and forecast 2023-2028
o Exhibit 34: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
o 6.4 Retail pharmacies - Market size and forecast 2023-2028
o Exhibit 38: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 40: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
o 6.5 Online pharmacies - Market size and forecast 2023-2028
o Exhibit 42: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 43: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 44: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
o 6.6 Market opportunity by Distribution Channel
o Exhibit 46: Market opportunity by Distribution Channel ($ billion)
o Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ billion)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 48: Chart on Type - Market share 2023-2028 (%)
o Exhibit 49: Data Table on Type - Market share 2023-2028 (%)
o 7.2 Comparison by Type
o Exhibit 50: Chart on Comparison by Type
o Exhibit 51: Data Table on Comparison by Type
o 7.3 Estrogen and progesterone replacement therapy - Market size and forecast 2023-2028
o Exhibit 52: Chart on Estrogen and progesterone replacement therapy - Market size and forecast 2023-2028 ($ billion)
o Exhibit 53: Data Table on Estrogen and progesterone replacement therapy - Market size and forecast 2023-2028 ($ billion)
o Exhibit 54: Chart on Estrogen and progesterone replacement therapy - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Estrogen and progesterone replacement therapy - Year-over-year growth 2023-2028 (%)
o 7.4 Thyroid hormone replacement therapy - Market size and forecast 2023-2028
o Exhibit 56: Chart on Thyroid hormone replacement therapy - Market size and forecast 2023-2028 ($ billion)
o Exhibit 57: Data Table on Thyroid hormone replacement therapy - Market size and forecast 2023-2028 ($ billion)
o Exhibit 58: Chart on Thyroid hormone replacement therapy - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Thyroid hormone replacement therapy - Year-over-year growth 2023-2028 (%)
o 7.5 HGH replacement therapy - Market size and forecast 2023-2028
o Exhibit 60: Chart on HGH replacement therapy - Market size and forecast 2023-2028 ($ billion)
o Exhibit 61: Data Table on HGH replacement therapy - Market size and forecast 2023-2028 ($ billion)
o Exhibit 62: Chart on HGH replacement therapy - Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on HGH replacement therapy - Year-over-year growth 2023-2028 (%)
o 7.6 Others - Market size and forecast 2023-2028
o Exhibit 64: Chart on Others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 65: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 66: Chart on Others - Year-over-year growth 2023-2028 (%)
o Exhibit 67: Data Table on Others - Year-over-year growth 2023-2028 (%)
o 7.7 Market opportunity by Type
o Exhibit 68: Market opportunity by Type ($ billion)
o Exhibit 69: Data Table on Market opportunity by Type ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 73: Chart on Geographic comparison
o Exhibit 74: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 Germany - Market size and forecast 2023-2028
o Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.9 China - Market size and forecast 2023-2028
o Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.10 UK - Market size and forecast 2023-2028
o Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.11 Japan - Market size and forecast 2023-2028
o Exhibit 107: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
o Exhibit 108: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
o Exhibit 109: Chart on Japan - Year-over-year growth 2023-2028 (%)
o Exhibit 110: Data Table on Japan - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 111: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 113: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 115: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 116: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 117: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 118: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 119: Abbott Laboratories - Overview
o Exhibit 120: Abbott Laboratories - Business segments
o Exhibit 121: Abbott Laboratories - Key news
o Exhibit 122: Abbott Laboratories - Key offerings
o Exhibit 123: Abbott Laboratories - Segment focus
o 12.4 AbbVie Inc.
o Exhibit 124: AbbVie Inc. - Overview
o Exhibit 125: AbbVie Inc. - Product / Service
o Exhibit 126: AbbVie Inc. - Key news
o Exhibit 127: AbbVie Inc. - Key offerings
o 12.5 Amgen Inc.
o Exhibit 128: Amgen Inc. - Overview
o Exhibit 129: Amgen Inc. - Product / Service
o Exhibit 130: Amgen Inc. - Key offerings
o 12.6 Bayer AG
o Exhibit 131: Bayer AG - Overview
o Exhibit 132: Bayer AG - Business segments
o Exhibit 133: Bayer AG - Key news
o Exhibit 134: Bayer AG - Key offerings
o Exhibit 135: Bayer AG - Segment focus
o 12.7 Besins Healthcare Monaco
o Exhibit 136: Besins Healthcare Monaco - Overview
o Exhibit 137: Besins Healthcare Monaco - Product / Service
o Exhibit 138: Besins Healthcare Monaco - Key offerings
o 12.8 Eli Lilly and Co.
o Exhibit 139: Eli Lilly and Co. - Overview
o Exhibit 140: Eli Lilly and Co. - Product / Service
o Exhibit 141: Eli Lilly and Co. - Key news
o Exhibit 142: Eli Lilly and Co. - Key offerings
o 12.9 Endo International Plc
o Exhibit 143: Endo International Plc - Overview
o Exhibit 144: Endo International Plc - Business segments
o Exhibit 145: Endo International Plc - Key news
o Exhibit 146: Endo International Plc - Key offerings
o Exhibit 147: Endo International Plc - Segment focus
o 12.10 F. Hoffmann La Roche Ltd.
o Exhibit 148: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 149: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 150: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 151: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 152: F. Hoffmann La Roche Ltd. - Segment focus
o 12.11 Merck KGaA
o Exhibit 153: Merck KGaA - Overview
o Exhibit 154: Merck KGaA - Business segments
o Exhibit 155: Merck KGaA - Key news
o Exhibit 156: Merck KGaA - Key offerings
o Exhibit 157: Merck KGaA - Segment focus
o 12.12 Mithra Pharmaceuticals SA
o Exhibit 158: Mithra Pharmaceuticals SA - Overview
o Exhibit 159: Mithra Pharmaceuticals SA - Product / Service
o Exhibit 160: Mithra Pharmaceuticals SA - Key offerings
o 12.13 Novartis AG
o Exhibit 161: Novartis AG - Overview
o Exhibit 162: Novartis AG - Business segments
o Exhibit 163: Novartis AG - Key offerings
o Exhibit 164: Novartis AG - Segment focus
o 12.14 Novo Nordisk AS
o Exhibit 165: Novo Nordisk AS - Overview
o Exhibit 166: Novo Nordisk AS - Business segments
o Exhibit 167: Novo Nordisk AS - Key offerings
o Exhibit 168: Novo Nordisk AS - Segment focus
o 12.15 Pfizer Inc.
o Exhibit 169: Pfizer Inc. - Overview
o Exhibit 170: Pfizer Inc. - Product / Service
o Exhibit 171: Pfizer Inc. - Key news
o Exhibit 172: Pfizer Inc. - Key offerings
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 173: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 174: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 175: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 176: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 177: Teva Pharmaceutical Industries Ltd. - Segment focus
o 12.17 Viatris Inc.
o Exhibit 178: Viatris Inc. - Overview
o Exhibit 179: Viatris Inc. - Business segments
o Exhibit 180: Viatris Inc. - Key news
o Exhibit 181: Viatris Inc. - Key offerings
o Exhibit 182: Viatris Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 183: Inclusions checklist
o Exhibit 184: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 185: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 186: Research methodology
o Exhibit 187: Validation techniques employed for market sizing
o Exhibit 188: Information sources
o 13.5 List of abbreviations
o Exhibit 189: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global hormone replacement therapy market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits31: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Distribution Channel ($ billion)
Exhibits47: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits48: Chart on Type - Market share 2023-2028 (%)
Exhibits49: Data Table on Type - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Type
Exhibits51: Data Table on Comparison by Type
Exhibits52: Chart on Estrogen and progesterone replacement therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Estrogen and progesterone replacement therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Estrogen and progesterone replacement therapy - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Estrogen and progesterone replacement therapy - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Thyroid hormone replacement therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Thyroid hormone replacement therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Thyroid hormone replacement therapy - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Thyroid hormone replacement therapy - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on HGH replacement therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits61: Data Table on HGH replacement therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits62: Chart on HGH replacement therapy - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on HGH replacement therapy - Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits65: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits66: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits68: Market opportunity by Type ($ billion)
Exhibits69: Data Table on Market opportunity by Type ($ billion)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits108: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits109: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ billion)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits113: Impact of drivers and challenges in 2023 and 2028
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: Abbott Laboratories - Overview
Exhibits120: Abbott Laboratories - Business segments
Exhibits121: Abbott Laboratories - Key news
Exhibits122: Abbott Laboratories - Key offerings
Exhibits123: Abbott Laboratories - Segment focus
Exhibits124: AbbVie Inc. - Overview
Exhibits125: AbbVie Inc. - Product / Service
Exhibits126: AbbVie Inc. - Key news
Exhibits127: AbbVie Inc. - Key offerings
Exhibits128: Amgen Inc. - Overview
Exhibits129: Amgen Inc. - Product / Service
Exhibits130: Amgen Inc. - Key offerings
Exhibits131: Bayer AG - Overview
Exhibits132: Bayer AG - Business segments
Exhibits133: Bayer AG - Key news
Exhibits134: Bayer AG - Key offerings
Exhibits135: Bayer AG - Segment focus
Exhibits136: Besins Healthcare Monaco - Overview
Exhibits137: Besins Healthcare Monaco - Product / Service
Exhibits138: Besins Healthcare Monaco - Key offerings
Exhibits139: Eli Lilly and Co. - Overview
Exhibits140: Eli Lilly and Co. - Product / Service
Exhibits141: Eli Lilly and Co. - Key news
Exhibits142: Eli Lilly and Co. - Key offerings
Exhibits143: Endo International Plc - Overview
Exhibits144: Endo International Plc - Business segments
Exhibits145: Endo International Plc - Key news
Exhibits146: Endo International Plc - Key offerings
Exhibits147: Endo International Plc - Segment focus
Exhibits148: F. Hoffmann La Roche Ltd. - Overview
Exhibits149: F. Hoffmann La Roche Ltd. - Business segments
Exhibits150: F. Hoffmann La Roche Ltd. - Key news
Exhibits151: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits152: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits153: Merck KGaA - Overview
Exhibits154: Merck KGaA - Business segments
Exhibits155: Merck KGaA - Key news
Exhibits156: Merck KGaA - Key offerings
Exhibits157: Merck KGaA - Segment focus
Exhibits158: Mithra Pharmaceuticals SA - Overview
Exhibits159: Mithra Pharmaceuticals SA - Product / Service
Exhibits160: Mithra Pharmaceuticals SA - Key offerings
Exhibits161: Novartis AG - Overview
Exhibits162: Novartis AG - Business segments
Exhibits163: Novartis AG - Key offerings
Exhibits164: Novartis AG - Segment focus
Exhibits165: Novo Nordisk AS - Overview
Exhibits166: Novo Nordisk AS - Business segments
Exhibits167: Novo Nordisk AS - Key offerings
Exhibits168: Novo Nordisk AS - Segment focus
Exhibits169: Pfizer Inc. - Overview
Exhibits170: Pfizer Inc. - Product / Service
Exhibits171: Pfizer Inc. - Key news
Exhibits172: Pfizer Inc. - Key offerings
Exhibits173: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits174: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits175: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits176: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits177: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits178: Viatris Inc. - Overview
Exhibits179: Viatris Inc. - Business segments
Exhibits180: Viatris Inc. - Key news
Exhibits181: Viatris Inc. - Key offerings
Exhibits182: Viatris Inc. - Segment focus
Exhibits183: Inclusions checklist
Exhibits184: Exclusions checklist
Exhibits185: Currency conversion rates for US$
Exhibits186: Research methodology
Exhibits187: Validation techniques employed for market sizing
Exhibits188: Information sources
Exhibits189: List of abbreviations